In addition to classical exercise mimetics, metabolic modulators such as meldonium and trimetazidine may also contribute to the therapeutic potential of the AMPK/SIRT1/PGC-1α axis in MDD [113,114]. Here, SIRT1 is linked to major depressive disorder.